InfuSystem Holdings, Inc.
INFUAMEXHealthcare● Active
$9.06
$-0.18(-1.95%)
Market Cap$182846229
P/E Ratio—
52W High$11.04
52W Low$5.38
InfuSystem Holdings, Inc. (INFU) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
INFU · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 7, 2026EPS Actual
$0.05
Est. $0.04 · +25.0%
Revenue
$0.03B
Est. $0.03B · -1.9%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 7, 2026
After Market Close
▲ Beat EPS▼ Miss Revenue🔥 5-Quarter EPS Beat Streak
INFU reports quarterly as a AMEX-listed Medical - Instruments & Supplies company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $0.58B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$0.58B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 4, 2026 | $0.12 | — | — | — | $0.04B | — |
| ▲ Q2 FY2026 | May 7, 2026 | $0.04 | $0.05 | +25.0% | $0.03B | $0.03B | -1.9% |
| ▲ Q1 FY2026 | Feb 24, 2026 | $0.07 | $0.10 | +42.9% | $0.04B | $0.04B | -1.2% |
| ▲ Q4 FY2025 | Nov 4, 2025 | $0.08 | $0.11 | +37.5% | $0.04B | $0.04B | -0.5% |
| ▲ Q3 FY2025 | Aug 5, 2025 | $0.03 | $0.12 | +300.0% | $0.04B | $0.04B | -3.7% |
| ▲ Q2 FY2025 | May 8, 2025 | -$0.03 | -$0.01 | +66.7% | $0.03B | $0.04B | -3.7% |
| ▼ Q1 FY2025 | Mar 4, 2025 | $0.08 | $0.04 | -50.0% | $0.03B | $0.03B | +0.3% |
| ▲ Q4 FY2024 | Nov 7, 2024 | $0.06 | $0.08 | +33.3% | $0.04B | $0.03B | +1.2% |
Q3 FY2026
Aug 4, 2026
EPS Actual
—
EPS Est.
$0.12
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 7, 2026Beat
EPS Actual
$0.05
EPS Est.
$0.04
EPS Surpr.
+25.0%
Revenue
$0.03B
Q1 FY2026
Feb 24, 2026Beat
EPS Actual
$0.10
EPS Est.
$0.07
EPS Surpr.
+42.9%
Revenue
$0.04B
Q4 FY2025
Nov 4, 2025Beat
EPS Actual
$0.11
EPS Est.
$0.08
EPS Surpr.
+37.5%
Revenue
$0.04B
Q3 FY2025
Aug 5, 2025Beat
EPS Actual
$0.12
EPS Est.
$0.03
EPS Surpr.
+300.0%
Revenue
$0.04B
Q2 FY2025
May 8, 2025Beat
EPS Actual
-$0.01
EPS Est.
-$0.03
EPS Surpr.
+66.7%
Revenue
$0.03B
Q1 FY2025
Mar 4, 2025Miss
EPS Actual
$0.04
EPS Est.
$0.08
EPS Surpr.
-50.0%
Revenue
$0.03B
Q4 FY2024
Nov 7, 2024Beat
EPS Actual
$0.08
EPS Est.
$0.06
EPS Surpr.
+33.3%
Revenue
$0.04B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.17 | $0.17 | $0.17 | 1 |
| Q3 FY2027 | $0.17 | $0.17 | $0.17 | 1 |
| Q2 FY2027 | $0.14 | $0.14 | $0.14 | 1 |
| Q1 FY2027 | $0.06 | $0.06 | $0.06 | 1 |
| Q4 FY2026 | $0.14 | $0.14 | $0.14 | 1 |
| Q3 FY2026 | $0.13 | $0.13 | $0.13 | 2 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 2 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 7, 2026 | +25.0% | $10.14 | $8.97 | -11.54% |
| ▲ Q1 FY2026 | Feb 24, 2026 | +42.9% | $7.58 | $8.60 | +13.46% |
| ▲ Q4 FY2025 | Nov 4, 2025 | +37.5% | $10.40 | $9.46 | -9.04% |
| ▲ Q3 FY2025 | Aug 5, 2025 | +300.0% | $5.85 | $6.07 | +3.76% |
| ▲ Q2 FY2025 | May 8, 2025 | +66.7% | $4.75 | $5.47 | +15.16% |
| ▼ Q1 FY2025 | Mar 4, 2025 | -50.0% | $7.26 | $6.47 | -10.88% |
| ▲ Q4 FY2024 | Nov 7, 2024 | +33.3% | $6.98 | $7.34 | +5.16% |
| ▼ Q3 FY2024 | Aug 8, 2024 | -18.2% | $5.80 | $6.00 | +3.45% |
Q2 FY2026-11.54%
Report Date
May 7, 2026
EPS Beat/Miss
+25.0%
Price Before
$10.14
Price After
$8.97
Q1 FY2026+13.46%
Report Date
Feb 24, 2026
EPS Beat/Miss
+42.9%
Price Before
$7.58
Price After
$8.60
Q4 FY2025-9.04%
Report Date
Nov 4, 2025
EPS Beat/Miss
+37.5%
Price Before
$10.40
Price After
$9.46
Q3 FY2025+3.76%
Report Date
Aug 5, 2025
EPS Beat/Miss
+300.0%
Price Before
$5.85
Price After
$6.07
Q2 FY2025+15.16%
Report Date
May 8, 2025
EPS Beat/Miss
+66.7%
Price Before
$4.75
Price After
$5.47
Q1 FY2025-10.88%
Report Date
Mar 4, 2025
EPS Beat/Miss
-50.0%
Price Before
$7.26
Price After
$6.47
Q4 FY2024+5.16%
Report Date
Nov 7, 2024
EPS Beat/Miss
+33.3%
Price Before
$6.98
Price After
$7.34
Q3 FY2024+3.45%
Report Date
Aug 8, 2024
EPS Beat/Miss
-18.2%
Price Before
$5.80
Price After
$6.00
Avg Beat Reaction+2.83%
Avg Miss Reaction-3.72%
Beat Rate6 / 8 quarters
Largest Move+15.16% (Q2 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: INFU ends December
InfuSystem Holdings, Inc. (INFU) most recently reported earnings on May 7, 2026 for Q2 FY2026, posting EPS of $0.05 — beating the analyst consensus of $0.04 by +25.0%. INFU has beaten EPS estimates for 5 consecutive quarters. The next INFU earnings date is expected around September 1, 2026.
Each quarter, investors track INFU earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. INFU revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
INFU's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
INFU earnings · 5 questionsInfuSystem Holdings, Inc.'s next earnings report is expected around September 1, 2026. INFU typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; INFU historically reports after market close (AMC).
INFU earnings datewhen is INFU earningsINFU next earnings datewhen does INFU report earningsINFU earnings calendar
▸ Source: FMP · InfuSystem Holdings, Inc. SEC filings · US GAAP · InfuSystem Holdings, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026